Literature DB >> 12472134

Malignant pleural effusions.

Joe B Putnam1.   

Abstract

The management of pleural effusions and, in particular, recurrent MPE require an accurate assessment of the characteristics of the pleural fluid and the relief of the patient's symptoms. Although a common problem, treatment of pleural effusions and MPE is highly variable. Selection of optimal treatment for the individual patient (or population of patients) requires a careful assessment of the benefits and associated risks of the therapy. Pleurodesis is an artificial measure of success that is hospital centered, not patient centered. Because patients with MPE have limited life expectancy, efforts to palliate or eliminate dyspnea, optimize function, eliminate hospitalization, and reduce excessive end-of-life medical care costs may be best achieved with a chronic indwelling pleural catheter. The need for expensive supplies may temper the use of such outpatient management. Alternative techniques of tube thoracostomy, drainage, and sclerosis or thoracoscopy with drainage and talc poudrage also have benefits but are associated with variable hospitalization and increased medical costs.

Entities:  

Mesh:

Year:  2002        PMID: 12472134     DOI: 10.1016/s0039-6109(02)00036-1

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  8 in total

Review 1.  Minimally invasive palliative interventions in advanced lung cancer.

Authors:  Christopher Mallow; Margaret Hayes; Roy Semaan; Thomas Smith; Russell Hales; Roy Brower; Lonny Yarmus
Journal:  Expert Rev Respir Med       Date:  2018-06-19       Impact factor: 3.772

2.  Rapid pleurodesis is an outpatient alternative in patients with malignant pleural effusions: a prospective randomized controlled trial.

Authors:  Serkan Özkul; Akif Turna; Ahmet Demirkaya; Burcu Aksoy; Kamil Kaynak
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

3.  Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Authors:  Ozkan Demirhan; Cetin Ordu; Alper Toker
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

4.  Sodium hydroxide as a sclerosing agent in patients with neoplastic pleural effusion non-candidates for VATS: results of a minimally invasive protocol.

Authors:  Micaela Raices; Matías E Czerwonko; Agustin Dietrich; Alejandro Da Lozzo; Enrique Beveraggi; David Smith
Journal:  Updates Surg       Date:  2017-08-31

5.  Caring for a patient with malignant pleural effusion.

Authors:  Jeanne Held-Warmkessel; Linda Schiech
Journal:  Nursing       Date:  2008-11

6.  Pleural effusions in children undergoing cardiac surgery.

Authors:  Sachin Talwar; Sandeep Agarwala; Chander Mohan Mittal; Shiv Kumar Choudhary; Balram Airan
Journal:  Ann Pediatr Cardiol       Date:  2010-01

Review 7.  The treatment of pleural carcinosis with malignant pleural effusion.

Authors:  Michael Ried; Hans-Stefan Hofmann
Journal:  Dtsch Arztebl Int       Date:  2013-05       Impact factor: 5.594

8.  Implantation of permanent pleural catheter for palliation of malignant pleural effusion.

Authors:  Michelle Meier; Marie Riis Mortensen; Lene Unmack Larsen
Journal:  Cancer Manag Res       Date:  2016-11-08       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.